World's Best Scientists 2026 revealed!

Stéphane De Wit publications per year

The chart shows the history of publications by Stéphane De Wit between 1983 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Stéphane De Wit published across 43 years, from 1983 to 2025, averaging 3.8 papers a year. Output peaked at 20 publications in 2013. 7 of the 165 publications appeared in the last two years.

No. of publications
5 10 15 20
Bar chart. Horizontal axis: year, 1983 to 2025. Vertical axis: number of publications, 0 to 20. Peak 20 publications in 2013. 1983: 1 publication 1984: 0 publications 1985: 2 publications 1986: 0 publications 1987: 0 publications 1988: 0 publications 1989: 0 publications 1990: 0 publications 1991: 0 publications 1992: 0 publications 1993: 1 publication 1994: 3 publications 1995: 1 publication 1996: 1 publication 1997: 2 publications 1998: 0 publications 1999: 0 publications 2000: 0 publications 2001: 2 publications 2002: 1 publication 2003: 1 publication 2004: 5 publications 2005: 11 publications 2006: 5 publications 2007: 3 publications 2008: 7 publications 2009: 5 publications 2010: 11 publications 2011: 7 publications 2012: 10 publications 2013: 20 publications 2014: 9 publications 2015: 8 publications 2016: 8 publications 2017: 3 publications 2018: 10 publications 2019: 4 publications 2020: 4 publications 2021: 7 publications 2022: 3 publications 2023: 3 publications 2024: 5 publications 2025: 2 publications
1983 2025

165 publications in total across all disciplines

View publications per year as a table
Stéphane De Wit: publications per year, 1983 to 2025
Year Publications
1983 1
1984 0
1985 2
1986 0
1987 0
1988 0
1989 0
1990 0
1991 0
1992 0
1993 1
1994 3
1995 1
1996 1
1997 2
1998 0
1999 0
2000 0
2001 2
2002 1
2003 1
2004 5
2005 11
2006 5
2007 3
2008 7
2009 5
2010 11
2011 7
2012 10
2013 20
2014 9
2015 8
2016 8
2017 3
2018 10
2019 4
2020 4
2021 7
2022 3
2023 3
2024 5
2025 2
Total 165
Download as CSV

Stéphane De Wit publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Stéphane De Wit sits on this spectrum.

No. of scientists
200 400 600 800
Bar chart with 100 bars. Horizontal axis: publications, 47–56 to 1,028+. Vertical axis: number of scientists, 0 to 980. Most scientists, 980, have 127–136 publications. The last bar groups every scientist with 1,028 publications or more. 47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 413 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 848 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 949 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 840 scientists 207–216 publications: 733 scientists 217–226 publications: 708 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 417 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 196 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 59 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientist 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientist 1,028+ publications: 100 scientists
47–56 publications 1,028+

The last bar groups every scientist with 1,028 publications or more.

View publications distribution as a table
Number of Biology and Biochemistry scientists by publication count, Research.com 2026 ranking edition. Based on 19,587 ranked scientists.
Publications Scientists
47–56 8
57–66 35
67–76 106
77–86 231
87–96 413
97–106 546
107–116 704
117–126 848
127–136 980
137–146 942
147–156 969
157–166 949
167–176 951
177–186 915
187–196 787
197–206 840
207–216 733
217–226 708
227–236 651
237–246 605
247–256 510
257–266 524
267–276 434
277–286 417
287–296 350
297–306 363
307–316 315
317–326 296
327–336 261
337–346 240
347–356 219
357–366 196
367–376 154
377–386 161
387–396 155
397–406 145
407–416 124
417–426 112
427–436 132
437–446 116
447–456 99
457–466 81
467–476 91
477–486 80
487–496 80
497–506 59
507–516 36
517–526 46
527–536 54
537–546 44
547–556 43
557–566 43
567–576 42
577–586 25
587–596 34
597–606 23
607–616 33
617–626 31
627–636 27
637–646 25
647–656 28
657–666 34
667–676 18
677–686 16
687–696 10
697–706 12
707–716 21
717–726 12
727–736 12
737–746 10
747–756 7
757–766 13
767–776 15
777–786 13
787–796 9
797–806 9
807–816 7
817–826 4
827–836 9
837–846 7
847–856 3
857–866 5
867–876 5
877–886 11
887–896 3
897–906 4
907–916 7
917–926 5
927–936 6
937–946 6
947–956 3
957–966 7
967–976 2
977–986 2
987–996 1
997–1,006 5
1,007–1,016 2
1,017–1,026 2
1,027 1
1,028+ 100
Download as CSV

Stéphane De Wit D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Stéphane De Wit sits on this spectrum.

No. of scientists
250 500 750 1,000 1,250
Bar chart with 65 bars. Horizontal axis: D-Index, 40–41 to 167+. Vertical axis: number of scientists, 0 to 1,253. Most scientists, 1,253, have 58–59 D-Index. The last bar groups every scientist with 167 D-Index or more. 40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 316 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 899 scientists 52–53 D-Index: 1,025 scientists 54–55 D-Index: 1,149 scientists 56–57 D-Index: 1,235 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,162 scientists 62–63 D-Index: 1,130 scientists 64–65 D-Index: 1,031 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 714 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 71 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40–41 D-Index 167+

The last bar groups every scientist with 167 D-Index or more.

View D-Index distribution as a table
Number of Biology and Biochemistry scientists by D-index, Research.com 2026 ranking edition. Based on 19,587 ranked scientists.
D-Index Scientists
40–41 80
42–43 183
44–45 316
46–47 504
48–49 718
50–51 899
52–53 1,025
54–55 1,149
56–57 1,235
58–59 1,253
60–61 1,162
62–63 1,130
64–65 1,031
66–67 897
68–69 814
70–71 714
72–73 709
74–75 596
76–77 512
78–79 473
80–81 412
82–83 373
84–85 358
86–87 285
88–89 273
90–91 227
92–93 208
94–95 193
96–97 153
98–99 157
100–101 148
102–103 120
104–105 113
106–107 100
108–109 86
110–111 67
112–113 71
114–115 73
116–117 64
118–119 53
120–121 60
122–123 54
124–125 43
126–127 38
128–129 49
130–131 26
132–133 18
134–135 23
136–137 32
138–139 32
140–141 27
142–143 19
144–145 22
146–147 12
148–149 16
150–151 14
152–153 10
154–155 13
156–157 10
158–159 7
160–161 9
162–163 13
164–165 4
166 4
167+ 98
Download as CSV

Overview

Stéphane De Wit is affiliated with the Université Libre de Bruxelles in Belgium, focusing primarily on medical research related to infectious diseases and HIV. The scientist's research contributions center extensively on HIV-related health complications and treatments, with a particular emphasis on antiretroviral therapy and its implications for patient health.

De Wit's published work highlights various aspects of HIV treatment outcomes and associated health risks. Notable recent papers include:

  • "Incidence of hypertension in people with HIV who are treated with integrase inhibitors versus other antiretroviral regimens in the RESPOND cohort consortium," 2022, HIV Medicine
  • "Contemporary antiretrovirals and body-mass index: a prospective study of the RESPOND cohort consortium," 2021, The Lancet HIV
  • "Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed People with HIV Aged ≥ 65 Years: Week 48 Results of a Phase 3b, Open-Label Trial," 2021, Infectious Diseases and Therapy
  • "Associations between change in BMI and the risk of hypertension and dyslipidaemia in people receiving integrase strand-transfer inhibitors, tenofovir alafenamide, or both compared with other contemporary antiretroviral regimens: a multicentre, prospective observational study from the RESPOND consortium cohorts," 2024, The Lancet HIV
  • "Measures of Longitudinal Immune Dysfunction and Risk of AIDS and Non-AIDS Defining Malignancies in Antiretroviral-Treated People With Human Immunodeficiency Virus," 2023, Clinical Infectious Diseases

De Wit's research spans a range of specialized topics, including:

  • HIV-related health complications and treatments
  • HIV/AIDS drug development and treatment
  • HIV/AIDS Research and Interventions
  • HIV Research and Treatment
  • Mosquito-borne diseases and control
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Virology and Viral Diseases

Main fields of study include Medicine, with a significant subfield focus on Infectious Diseases. Additional subfields represented in De Wit's work are Emergency Medicine, Virology, Epidemiology, and Public Health, Environmental and Occupational Health.

Frequent publication venues for De Wit include:

  • The Lancet HIV
  • International Journal of Cardiology
  • AIDS
  • HIV Medicine
  • Clinical Infectious Diseases

Throughout their career, De Wit has collaborated with several researchers frequently associated with HIV and infectious disease research. These frequent coauthors include Lene Ryom, Amanda Mocroft, Matthew Law, Antonella d'Arminio Monforte, and Christoph Stephan.

Best Publications

  • Combination antiretroviral therapy and the risk of myocardial infarction

    Nina Friis-Møller;Caroline A Sabin;Rainer Weber;Antonella d'Arminio Monforte

  • Class of antiretroviral drugs and the risk of myocardial infarction.

    Nina Friis-Moller;Peter Reiss;Caroline A. Sabin;Rainer Weber

  • Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study

    Alison J Rodger;Valentina Cambiano;Tina Bruun;Pietro Vernazza

  • Risk of Myocardial Infarction in Patients with HIV Infection Exposed to Specific Individual Antiretroviral Drugs from the 3 Major Drug Classes: The Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study

    Signe Westring Worm;Caroline Sabin;Rainer Weber;Peter Reiss

  • Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort

    Deborah Konopnicki;Amanda Mocroft;S. De Wit;Francisco Antunes

  • Inflammation, Coagulation and Cardiovascular Disease in HIV-Infected Individuals

    Daniel A. Duprez;Jacqueline Neuhaus;Lewis H. Kuller;Russell Tracy

  • Incidence and risk factors for new-onset diabetes in HIV-infected patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study.

    Stéphane De Wit;Caroline Sabin;Rainer Weber;Signe Westring Worm

  • Risk Factors and Outcomes for Late Presentation for HIV-Positive Persons in Europe: Results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE).

    Amanda Mocroft;Jens D Lundgren;Jens D Lundgren;Miriam Lewis Sabin;Antonella d'Arminio Monforte

  • An In-Depth Comparison of Latency-Reversing Agent Combinations in Various In Vitro and Ex Vivo HIV-1 Latency Models Identified Bryostatin-1+JQ1 and Ingenol-B+JQ1 to Potently Reactivate Viral Gene Expression.

    Gilles Darcis;Anna Kula;Sophie Bouchat;Koh Fujinaga

  • Microglial Cells: The Main HIV-1 Reservoir in the Brain

    Clementine Wallet;Marco De Rovere;Jeanne Van Assche;Fadoua Daouad

  • All-cause mortality in treated HIV-infected adults with CD4 ≥500/mm3 compared with the general population: evidence from a large European observational cohort collaboration

    Charlotte Lewden;Vincent Bouteloup;Stéphane De Wit

  • Synergistic activation of HIV-1 expression by deacetylase inhibitors and prostratin: implications for treatment of latent infection

    Sophie Reuse;Miriam Calao;Kabamba Kabeya;Allan Guiguen

  • Efficacy and Safety of Switching to Dolutegravir/Lamivudine Fixed-Dose 2-Drug Regimen vs Continuing a Tenofovir Alafenamide-Based 3- or 4-Drug Regimen for Maintenance of Virologic Suppression in Adults Living With Human Immunodeficiency Virus Type 1: Phase 3, Randomized, Noninferiority TANGO Study.

    Jean van Wyk;Faïza Ajana;Fiona Bisshop;Stéphane De Wit

  • HIV and syphilis: when to perform a lumbar puncture.

    Agnès Libois;Stéphane De Wit;Bénédicte Poll;Felipe F. García

  • CD4 cell count and the risk of AIDS or death in HIV-Infected adults on combination antiretroviral therapy with a suppressed viral load: a longitudinal cohort study from COHERE

    Jim Young;Mina Psichogiou;Laurence Meyer

  • Long-term Mortality in HIV-Positive Individuals Virally Suppressed for > 3 Years With Incomplete CD4 Recovery

    Frederik N. Engsig;Robert Zangerle;Olga Katsarou;Francois Dabis

  • Acute hepatitis C in HIV-infected individuals : recommendations from the European AIDS Treatment Network (NEAT) consensus conference The European AIDS Treatment Network (NEAT) Acute Hepatitis C Infection Consensus Panel

    Matthieu Albert;Jose Benito;Sanjay Bhagani;Christoph Boesecke

  • Histone methyltransferase inhibitors induce HIV-1 recovery in resting CD4(+) T cells from HIV-1-infected HAART-treated patients.

    Sophie Bouchat;Jean-Stéphane Gatot;Kabamba Kabeya;Christelle Cardona

  • Remdesivir for Severe COVID-19 versus a Cohort Receiving Standard of Care.

    Susan A Olender;Katherine K Perez;Alan S Go;Bindu Balani

  • Predictors of Hypertension and Changes of Blood Pressure in HIV-Infected Patients:

    Rodolphe Thiebaut;Wafaa El-Sadr;Nina Friis-Møller;Martin M. Rickenbach

Frequent Co-Authors

Nathan Clumeck
Nathan Clumeck Université Libre de Bruxelles
Peter Reiss
Peter Reiss University of Amsterdam
Caroline Sabin
Caroline Sabin University College London
Andrew N. Phillips
Andrew N. Phillips University College London
Rainer Weber
Rainer Weber University of Zurich
Carine Van Lint
Carine Van Lint Université Libre de Bruxelles
Cristina Mussini
Cristina Mussini University of Modena and Reggio Emilia
Antonella Castagna
Antonella Castagna Vita-Salute San Raffaele University
Christine Katlama
Christine Katlama Sorbonne University
Véronique Avettand-Fenoel
Véronique Avettand-Fenoel Necker-Enfants Malades Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Biology and Biochemistry in the USA opens the door to a range of specialized online degree programs and certifications in allied fields. For those interested in human biology, health sciences, or fitness, exploring a fitness degrees online can be a valuable stepping stone toward a career in exercise science or sports medicine.

Another popular pathway is pursuing a kinesiology online degree, which delves into human movement and can lead to roles in rehabilitation, athletics, or wellness coaching. For students seeking fast-tracked healthcare specializations, the shortest pmhnp certificate program offers a quick way to become a Psychiatric-Mental Health Nurse Practitioner.

Additionally, candidates with a master’s degree can consider the cheapest post master's fnp program, an affordable path toward becoming a Family Nurse Practitioner. Whether you’re focused on research, patient care, or health education, these flexible online programs provide convenient routes for professional growth and diversification in the dynamic life sciences sector.

Best Scientists Citing Stéphane De Wit

Trending Scientists

Recently Published Articles